Administration Protocol for Packed Red Blood Cells (PRBCs)
Transfuse PRBCs one unit at a time, reassess the patient clinically after each unit, and only proceed with additional units if clinically indicated—this single-unit strategy prevents overtransfusion and associated complications including transfusion-associated circulatory overload. 1, 2
Pre-Transfusion Requirements
- Verify ABO compatibility through crossmatching before administering any PRBC unit 2
- Ensure the unit has not been left out of controlled temperature storage (2-6°C) for more than 30 minutes before transfusion begins 3
- Complete the entire transfusion within 4 hours of removing the unit from refrigerated storage 3
Transfusion Thresholds
Hemodynamically Stable Patients
- Transfuse when hemoglobin falls below 7 g/dL in stable critically ill patients, including those requiring mechanical ventilation and resuscitated trauma patients 1, 2
- This restrictive strategy (trigger <7 g/dL) is as safe and effective as liberal strategies (trigger <10 g/dL) and avoids unnecessary transfusion risks 1, 2
Patients with Cardiovascular Disease
- Consider transfusion at hemoglobin ≤8 g/dL in patients with preexisting cardiovascular disease, acute coronary syndromes, or symptoms of inadequate tissue oxygenation 1, 2, 4
- In patients with severe ischemic heart disease, transfusion may be beneficial when hemoglobin is <8 g/dL, though the exact threshold remains undefined 1
Active Hemorrhage
- In acute hemorrhage scenarios, transfusion thresholds may need adjustment, but once hemorrhage is controlled and the patient is hemodynamically stable, revert to the restrictive strategy 1
Single-Unit Transfusion Strategy
The cornerstone of safe PRBC administration is the single-unit approach:
- Order and transfuse one unit only 1, 2
- Monitor the patient during transfusion for adverse reactions 2
- Reassess clinically after the unit is complete before deciding on additional transfusion 1, 2
- Remeasure hemoglobin post-transfusion (each 300 mL unit typically raises hemoglobin by approximately 1 g/dL in normal-sized adults without ongoing blood loss) 2
- Evaluate clinical symptoms, vital signs, and evidence of tissue hypoxia 2, 4
Clinical Assessment Beyond Hemoglobin
Do not transfuse based solely on a hemoglobin number—always incorporate the following clinical parameters: 2, 4
- Symptoms of anemia: fatigue, dyspnea, chest pain, altered mental status, tachycardia 2, 4
- Comorbidities: cardiovascular disease, respiratory failure, renal disease 2, 4
- Volume status: assess for hypovolemia versus volume overload 1
- Biochemical markers of tissue hypoxia: lactate elevation, base deficit 2
- Hemodynamic stability: blood pressure, heart rate, urine output 1
Expected Hemoglobin Response
- Each unit of PRBCs (300 mL) contains 42.5-80 g of hemoglobin with a hematocrit of 50-80% 2
- Expect approximately 1 g/dL increase in hemoglobin per unit in a normal-sized adult without ongoing blood loss 2
- If the hemoglobin rise is less than expected, investigate ongoing bleeding, hemolysis, or dilution 2
Special Considerations in Trauma
Massive Transfusion Protocol
- In patients with massive hemorrhage requiring massive transfusion protocol activation, use a fresh frozen plasma (FFP): platelet: PRBC ratio of 1:1:1 to 1:1:1.5 to reduce 24-hour mortality 1
- This balanced resuscitation approach should be implemented within the first 6 hours of resuscitation 1
Transfusion-Related Risks in Trauma
- Early transfusion of >6 units of PRBCs within the first 12 hours post-injury is an independent predictor of multiple organ failure 5, 6, 7
- Each additional unit of PRBCs transfused confers a 6% higher risk of acute respiratory distress syndrome (ARDS) in trauma patients 5
- Conservative transfusion strategies that decrease PRBC exposure by even 1 unit may reduce the risk of ARDS 5
Common Pitfalls to Avoid
- Never order multiple units simultaneously without clinical reassessment between units—this leads to overtransfusion and increased complications 1, 2
- Do not fixate on hemoglobin thresholds alone—always assess the patient's symptoms, comorbidities, and evidence of tissue hypoxia 2, 4
- Avoid transfusing to arbitrary "normal" hemoglobin levels (e.g., 10 g/dL)—there is no benefit to liberal transfusion strategies in most critically ill patients 1, 2
- Do not assume transfusion is benign—PRBCs carry risks including venous thromboembolism, arterial thromboembolism, transfusion-related acute lung injury, and transfusion-associated circulatory overload 2
- Monitor for volume overload, especially in patients with cardiovascular or renal disease—the concentrated formulation of PRBCs minimizes this risk compared to whole blood, but vigilance is still required 2
Monitoring During and After Transfusion
- Monitor vital signs at baseline, 15 minutes after starting transfusion, and at completion 2
- Watch for transfusion reactions: febrile nonhemolytic reactions (most common), allergic reactions, acute hemolytic reactions, transfusion-related acute lung injury, and transfusion-associated circulatory overload 2
- Reassess clinical status after each unit: symptoms, vital signs, urine output, mental status 1, 2
- Remeasure hemoglobin after transfusion to guide further management 1, 2